Stable liquid formulation of human growth hormone
US8409586B2 · kind B2 · utility
1Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 6, 2006 |
| Grant date | Apr 2, 2013 |
| Priority date | — |
| Expiry date | Jun 28, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P5/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein is a stable liquid formulation comprising human growth hormone; L-lysine, L-arginine or polyethylene glycol 300; and poly(oxyethylene) poly(oxypropylene) copolymer, polyethylene glycol-15 polyoxystearate or polyethylene glycol-35 castor oil.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.